DIOVAN: payments to doctors
Payments that named DIOVAN as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $59K
- Providers
- 72
- Transactions
- 102
- Average per transaction
- $582
The per-transaction average — $582 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 72 providers the average total is $825, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novartis | $45,321 | 76.3% |
| Novartis Pharma AG | $14,080 | 23.7% |